This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, colon cancer, skin cancer, lymphoma, and other cancers. The text also reviews available screening modalities and their efficacies in reducing the risk of cancer, surgical indications to reduce the risk of cancer, and the use of biologic drugs to treat malignancies. Written by experts in the field, is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.weiterlesen